Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Orlow

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|May 26, 1999
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterizationF Rabbani, V M Richon, I Orlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor developmentM Orjuela, V P Castaneda, C Ridaura, et al.
The American Journal of Pathology|May 1, 1995
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppressionN A Gruis, J Weaver-Feldhaus, Q Liu, et al.
Human Pathology|June 19, 2001
Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastomaM Orjuela, I Orlow, M Dudas, et al.
Journal of the National Cancer Institute|October 18, 1995
Deletion of the p16 and p15 genes in human bladder tumorsI Orlow, L Lacombe, G J Hannon, et al.
Cancer Research|March 15, 1996
Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumorsI Orlow, A Iavarone, S J Crider-Miller, et al.
Journal of Neuro-Oncology|November 24, 2017
A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomasD D Correa, M Kryza-Lacombe, X Zhou, et al.
Cell|April 7, 1998
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53J Pomerantz, N Schreiber-Agus, N J Liégeois, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 13, 2004
Estimating the relative risk of developing melanoma in INK4A carriersM Berwick, I Orlow, S Mahabir, et al.
The British Journal of Dermatology|October 14, 2014
Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC)I Orlow, J M Satagopan, M Berwick, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|May 26, 1999
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterizationF Rabbani, V M Richon, I Orlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor developmentM Orjuela, V P Castaneda, C Ridaura, et al.
The American Journal of Pathology|May 1, 1995
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppressionN A Gruis, J Weaver-Feldhaus, Q Liu, et al.
Human Pathology|June 19, 2001
Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastomaM Orjuela, I Orlow, M Dudas, et al.
Journal of the National Cancer Institute|October 18, 1995
Deletion of the p16 and p15 genes in human bladder tumorsI Orlow, L Lacombe, G J Hannon, et al.
Cancer Research|March 15, 1996
Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumorsI Orlow, A Iavarone, S J Crider-Miller, et al.
Journal of Neuro-Oncology|November 24, 2017
A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomasD D Correa, M Kryza-Lacombe, X Zhou, et al.
Cell|April 7, 1998
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53J Pomerantz, N Schreiber-Agus, N J Liégeois, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 13, 2004
Estimating the relative risk of developing melanoma in INK4A carriersM Berwick, I Orlow, S Mahabir, et al.
The British Journal of Dermatology|October 14, 2014
Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC)I Orlow, J M Satagopan, M Berwick, et al.
Pageof 4